Unicept Pharma Private Limited - Company Profile

It is a pharma private limited company based in Karmanghat, Telangana, India, established in 2013.
2013 Karmanghat, Telangana, India Active
Last Updated:
Access Report
About Unicept Pharma Private Limited

Unicept Pharma Private Limited, a active private limited company, was established on 02 September 2013 in Karmanghat, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232TG2013PTC089820. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Jyotsna Polepally (Director), Vinaya Kathagandla (Director). Past directors included Kethavat Ashok Kumar, Vijayadurga Nadakuditi, Jyotsna Polepally. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Plot No.39, Door No.10-1-74/8/1/, 5Th Floor Yashoda Pride, Near Bajaj Electronics,Li, Ngojiguda, Karmanghat, Telangana, 500079.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232TG2013PTC089820

  • Registration Number

    089820

  • Incorporation Date

    02 September 2013

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 12 Year, 5 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth **** %
  • Profit Growth **** -115.73%
  • Ebitda **** -133.64%
  • Net Worth -9.86%
  • Total Assets **** 126.90%
Company report

Unicept Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Unicept Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Unicept Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Jyotsna Polepally Director 18 Apr 2018 Current
Vinaya Kathagandla Director 18 Apr 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 27 Sep 2018 Past
Pramod Abcsdd Additional Director 27 Sep 2018 Past
Pramod Abcsdd Additional Director 27 Sep 2018 Past
Pramod Abcsdd Director 18 Apr 2018 Past
Pramod Abcsdd Director 27 Apr 2018 Past
Pramod Abcsdd Additional Director 27 Sep 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Unicept Pharma.

Unicept Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 115.73% decrease in profit. The company's net worth dipped by a decrease of 9.86%.

Unicept Pharma revenue growth over time
Unicept Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 126.90%
*******
*******
*******
*******
Profit or Loss
*******
 -115.73%
*******
*******
*******
*******
Net Worth
*******
 -9.86%
*******
*******
*******
*******
EBITDA
*******
 -133.64%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Unicept Pharma?

In 2020, Unicept Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Unicept Pharma?

Unlock and access historical data on people associated with Unicept Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Unicept Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unicept Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Unicept Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Unicept Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Unicept Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was documented.

  • Director Appointment

    Jyotsna Polepally was appointed as a Director was appointed as a Director on 18 Apr 2018 & has been associated with this company since 7 years 10 months . was recorded as a recent event.

  • Director Appointment

    Progress on Vinaya Kathagandla was appointed as a Director was appointed as a Director on 18 Apr 2018 & has been associated with this company since 7 years 10 months . was documented.

  • Company Incorporation

    The activity Unicept Pharma Private Limited was registered on 02 Sep 2013 with Roc Hyderabad & aged 12 years 5 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Unicept Pharma Private Limited?

The CIN of Unicept Pharma Private Limited is U24232TG2013PTC089820.

Where is Unicept Pharma Private Limited headquartered?

Unicept Pharma Private Limited is headquartered at Plot No.39, Door No.10-1-74/8/1/, 5Th Floor Yashoda Pride, Near Bajaj Electronics,Li, Ngojiguda, Karmanghat, Telangana, 500079.

When was Unicept Pharma Private Limited incorporated?

Unicept Pharma Private Limited was incorporated on 02 September 2013.

Who are the current directors of Unicept Pharma Private Limited?

The current directors of Unicept Pharma Private Limited are

What is the primary industry of Unicept Pharma Private Limited?

The primary industry of Unicept Pharma Private Limited is Trade.

Is Unicept Pharma Private Limited a listed company?

Unicept Pharma Private Limited is unlisted.

What is the capital structure of Unicept Pharma Private Limited?

The authorized capital of Unicept Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Unicept Pharma Private Limited?

The compliance status of Unicept Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available